<DOC>
	<DOCNO>NCT02882789</DOCNO>
	<brief_summary>Primary - To investigate Pharmacokinetics , Safety , Tolerability Intravenous dosage form LCB01-0371 compare oral dosage Healthy Male Volunteers Secondary â€¢ To investigate absolute bio availability LCB01-0371 single intravenous dose</brief_summary>
	<brief_title>IV Dosage Form LCB01-0371 Phase I Study Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Healthy Male 19 39 year age time screen 2 . Subjects body mass index ( BMI ) 19 27 time screen 3 . Agree continue use medically reliable dual contraception donate sperm 28 day study completion 4 . Capable give write informed consent , willing participate clinical trial , willing comply study requirement 1 . History gastrointestinal problem ( e.g . Crohn 's disease , gastrointestinal ulcer ) affect absorption OR surgical history except appendectomy , herniotomy 2 . History allergy , cardiovascular , peripheral vascular , skin , mucous membrane , eye , otorhinolaryngologic , respiratory , musculoskeletal , infectious disease , gastroenterologic , liver , billiary , endocrinologic , kidney , genitourinary , neuropsychiatric , hematooncologic problem ( ) fracture etc .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>